In summary, although Th2 cells exert a protective function through the modulation of inflammation, they also intricately participate in the pathogenesis of NASH by promoting liver fibrosis via IL-13 signaling pathways. The gene discussed is IL13; the disease is metabolic dysfunction-associated steatohepatitis.